E
BioAdaptives, Inc.
BDPT
$0.0004
-$0.0001-20.00%
E
Sell
6/13/2023Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to E+ from E on 6/13/2023 due to an increase in the volatility index.
BioAdaptives, Inc. (BDPT) was upgraded to E+ from E on 6/13/2023 due to an increase in the volatility index.
E
Sell
3/14/2023Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to E from D- on 03/14/2023.
BioAdaptives, Inc. (BDPT) was downgraded to E from D- on 03/14/2023.
D
Sell
2/9/2023Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D- from E on 2/9/2023 due to an increase in the volatility index.
BioAdaptives, Inc. (BDPT) was upgraded to D- from E on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to E from D- on 2/8/2023 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.03 to 0.01, and debt to equity increased from -0.3 to -0.27.
BioAdaptives, Inc. (BDPT) was downgraded to E from D- on 2/8/2023 due to a decline in the volatility index, total return index and solvency index. The quick ratio declined from 0.03 to 0.01, and debt to equity increased from -0.3 to -0.27.
D
Sell
5/16/2022Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D- from E+ on 5/16/2022 due to a noticeable increase in the growth index and total return index. Total revenue increased 41.03% from $3.9 to $5.5, and EBIT increased 1.91% from -$177.7 to -$174.3.
BioAdaptives, Inc. (BDPT) was upgraded to D- from E+ on 5/16/2022 due to a noticeable increase in the growth index and total return index. Total revenue increased 41.03% from $3.9 to $5.5, and EBIT increased 1.91% from -$177.7 to -$174.3.
E
Sell
4/18/2022Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to E+ from D- on 4/18/2022 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.001 to -$0.0054, total revenue declined 26.42% from $5.3 to $3.9, and operating cash flow declined 6.63% from -$33.2 to -$35.4.
BioAdaptives, Inc. (BDPT) was downgraded to E+ from D- on 4/18/2022 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.001 to -$0.0054, total revenue declined 26.42% from $5.3 to $3.9, and operating cash flow declined 6.63% from -$33.2 to -$35.4.
D
Sell
11/11/2021Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to D- from D on 11/11/2021 due to a significant decline in the growth index, total return index and volatility index. EBIT declined 141.48% from -$71.6 to -$172.9, total revenue declined 13.11% from $6.1 to $5.3, and operating cash flow declined 11.78% from -$29.7 to -$33.2.
BioAdaptives, Inc. (BDPT) was downgraded to D- from D on 11/11/2021 due to a significant decline in the growth index, total return index and volatility index. EBIT declined 141.48% from -$71.6 to -$172.9, total revenue declined 13.11% from $6.1 to $5.3, and operating cash flow declined 11.78% from -$29.7 to -$33.2.
D
Sell
11/9/2021Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index and total return index.
BioAdaptives, Inc. (BDPT) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index and total return index.
E
Sell
11/8/2021Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and volatility index.
BioAdaptives, Inc. (BDPT) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and volatility index.
D
Sell
8/13/2021Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D from D- on 8/13/2021 due to a significant increase in the growth index and total return index. EBIT increased 66.53% from -$213.9 to -$71.6, operating cash flow increased 50.83% from -$60.4 to -$29.7, and earnings per share increased from -$0.0175 to -$0.01.
BioAdaptives, Inc. (BDPT) was upgraded to D from D- on 8/13/2021 due to a significant increase in the growth index and total return index. EBIT increased 66.53% from -$213.9 to -$71.6, operating cash flow increased 50.83% from -$60.4 to -$29.7, and earnings per share increased from -$0.0175 to -$0.01.
D
Sell
6/3/2021Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D- from E+ on 6/3/2021 due to an increase in the total return index and volatility index.
BioAdaptives, Inc. (BDPT) was upgraded to D- from E+ on 6/3/2021 due to an increase in the total return index and volatility index.
E
Sell
5/19/2021Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to E+ from D- on 5/19/2021 due to a decline in the total return index.
BioAdaptives, Inc. (BDPT) was downgraded to E+ from D- on 5/19/2021 due to a decline in the total return index.
D
Sell
4/16/2021Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D- from E+ on 4/16/2021 due to an increase in the total return index.
BioAdaptives, Inc. (BDPT) was upgraded to D- from E+ on 4/16/2021 due to an increase in the total return index.
E
Sell
4/1/2021Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to E+ from D- on 4/1/2021 due to a large decline in the growth index and volatility index. Earnings per share declined from -$0.0006 to -$0.008, and total revenue declined 15.91% from $4.4 to $3.7.
BioAdaptives, Inc. (BDPT) was downgraded to E+ from D- on 4/1/2021 due to a large decline in the growth index and volatility index. Earnings per share declined from -$0.0006 to -$0.008, and total revenue declined 15.91% from $4.4 to $3.7.
D
Sell
10/26/2020Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to D- from D on 10/26/2020 due to a decline in the total return index and volatility index.
BioAdaptives, Inc. (BDPT) was downgraded to D- from D on 10/26/2020 due to a decline in the total return index and volatility index.
D
Sell
8/14/2020Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D from D- on 8/14/2020 due to a large increase in the growth index and valuation index. Operating cash flow increased 52.25% from -$42.3 to -$20.2, and EBIT increased 47.19% from -$138.6 to -$73.2.
BioAdaptives, Inc. (BDPT) was upgraded to D from D- on 8/14/2020 due to a large increase in the growth index and valuation index. Operating cash flow increased 52.25% from -$42.3 to -$20.2, and EBIT increased 47.19% from -$138.6 to -$73.2.
D
Sell
4/15/2020Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to D- from D on 4/15/2020 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.02 to 0.
BioAdaptives, Inc. (BDPT) was downgraded to D- from D on 4/15/2020 due to a significant decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.02 to 0.
D
Sell
7/5/2017Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D from D- on 7/5/2017 due to an increase in the valuation index.
BioAdaptives, Inc. (BDPT) was upgraded to D from D- on 7/5/2017 due to an increase in the valuation index.
D
Sell
3/1/2017Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to D- from E+ on 3/1/2017 due to a large increase in the total return index and valuation index.
BioAdaptives, Inc. (BDPT) was upgraded to D- from E+ on 3/1/2017 due to a large increase in the total return index and valuation index.
E
Sell
12/1/2016Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to E+ from E on 12/1/2016 due to a noticeable increase in the total return index.
BioAdaptives, Inc. (BDPT) was upgraded to E+ from E on 12/1/2016 due to a noticeable increase in the total return index.
E
Sell
10/11/2016Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to E from E- on 10/11/2016 due to an increase in the volatility index and total return index.
BioAdaptives, Inc. (BDPT) was upgraded to E from E- on 10/11/2016 due to an increase in the volatility index and total return index.
E
Sell
9/26/2016Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to E- from E on 9/26/2016 due to a noticeable decline in the volatility index and total return index.
BioAdaptives, Inc. (BDPT) was downgraded to E- from E on 9/26/2016 due to a noticeable decline in the volatility index and total return index.
E
Sell
9/9/2016Upgraded
BioAdaptives, Inc. (BDPT) was upgraded to E from E- on 9/9/2016 due to an increase in the total return index, volatility index and valuation index.
BioAdaptives, Inc. (BDPT) was upgraded to E from E- on 9/9/2016 due to an increase in the total return index, volatility index and valuation index.
E
Sell
8/25/2016Downgrade
BioAdaptives, Inc. (BDPT) was downgraded to E- from E on 8/25/2016 due to a noticeable decline in the volatility index and total return index.
BioAdaptives, Inc. (BDPT) was downgraded to E- from E on 8/25/2016 due to a noticeable decline in the volatility index and total return index.
E
Sell
8/24/2016None
BioAdaptives, Inc. (BDPT) was downgraded to E from U on 08/24/2016.
BioAdaptives, Inc. (BDPT) was downgraded to E from U on 08/24/2016.
OTC PK
04/23/2024 3:55PM Eastern
Quotes delayed
